Holen Sie sich die Stockscreener-App
143.64
1.92%
-2.188
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$145.83
Offen:
$145.25
24-Stunden-Volumen:
192.75K
Relative Volume:
0.11
Marktkapitalisierung:
$22.03B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
18.19
EPS:
7.8957
Netto-Cashflow:
$943.00M
1W Leistung:
+6.46%
1M Leistung:
+8.25%
6M Leistung:
+46.79%
1J Leistung:
+2.40%
1-Tages-Spanne:
$142.44
$145.80
1-Wochen-Bereich:
$134.36
$151.34
52-Wochen-Spanne:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
144.18 | 22.28B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
610.40 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.82 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
710.58 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.72 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Precision Trading with Illumina Inc. (ILMN) Risk Zones - Stock Traders Daily
Will Illumina Inc. stock split again soon2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Illumina and PREMIA partner to expand clinical access to CGP in Asia - Devdiscourse
Illumina Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Is Illumina Inc ILU stock a momentum leaderJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - moha.gov.vn
What makes Illumina Inc. (ILU) stock appealing to growth investorsJuly 2025 Recap & Weekly Momentum Picks - ulpravda.ru
Illumina, Inc. Appoints Eric D. Green as Chief Medical Officer, Effective February 2, 2026 - MarketScreener
Biochips Market to Reach US$ 38.53 Billion by 2033, Growing at - openPR.com
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina launches cloud-based platform for multiomic data analysis - Investing.com
Illumina launches cloud-based platform for multiomic data analysis By Investing.com - Investing.com India
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis - PR Newswire
DNA Test Kits Market Booming with Rapid Growth Through 2033 |Devyser, Illumina, Inc., Living DNA Ltd - openPR.com
Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance UK
Next Generation Sequencing (NGS) Market to Reach US$ 35.92 - openPR.com
Illumina’s Crossroads: Genomics Pioneer Tests Investor Patience As Wall Street Reassesses The Stor - AD HOC NEWS
Generali Asset Management SPA SGR Has $2.11 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Forecast Cut: Is Illumina Inc stock a smart buy before Fed meetingTrade Exit Summary & AI Based Trade Execution Alerts - moha.gov.vn
Illumina Shares Slip After Citi Issues Bearish Rating Ahead of Earnings - MSN
Illumina (NASDAQ:ILMN) Lowered to "Hold" Rating by Zacks Research - MarketBeat
Illumina Inc.: Can the Genomics Pioneer Reinvent Itself for the AI Era? - AD HOC NEWS
Illumina (NASDAQ:ILMN) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Aug Macro: Is Illumina Inc stock dividend yield sustainable2025 Valuation Update & Entry Point Confirmation Signals - moha.gov.vn
Who Owns Illumina? Top Shareholders and Recent Insider Trades - TIKR.com
Biomarker Discovery Market to Reach US$ 54.19 Billion by 2033 - openPR.com
273,111 Shares in Illumina, Inc. $ILMN Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Earnings Are Growing at Illumina (NASDAQ:ILMN) but Shareholders Still Don't Like Its Prospects - 富途牛牛
Illumina stock at a crossroads: genomics giant tests investor patience as Wall Street recalibrates e - AD HOC NEWS
Here's Why Illumina (ILMN) is a Strong Momentum Stock - Yahoo Finance
Japan Nucleic Acid Isolation and Purification Market is Driven - openPR.com
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
ILLUMINA INC (NASDAQ:ILMN) Shows Bull Flag Setup Ahead of Potential Breakout - Chartmill
Illumina, Inc. $ILMN Shares Bought by Cwm LLC - MarketBeat
Pacer Advisors Inc. Acquires New Position in Illumina, Inc. $ILMN - MarketBeat
Voya Investment Management LLC Has $5.23 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
Take Profit: Is Illumina Inc. stock undervalued vs historical averagesJuly 2025 Short Interest & AI Driven Price Predictions - moha.gov.vn
Swedbank AB Grows Position in Illumina, Inc. $ILMN - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com
Illumina Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Genomics Market Outlook: Market to Reach US$ 118.2 Billion - openPR.com
Illumina Inc ILU Stock Analysis and ForecastTechnical Breakout Signals & Fast Growing Capital Growth - earlytimes.in
Is Illumina Inc Gaining or Losing Market Support? - Sahm
Illumina, Inc. $ILMN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat
Canaccord Genuity Maintains Illumina (ILMN) Hold Recommendation - Nasdaq
Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Nasdaq
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Douglas Lane & Associates LLC Acquires 18,914 Shares of Illumina, Inc. $ILMN - MarketBeat
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):